We are pleased to share the exciting news that Dr. Finkel’s study, titled “Therapeutic Antithrombotic Agent Use and Bleeding Risk in Retrobulbar Anesthesia for Outpatient Ophthalmic Surgery” has been published in the Cureus Journal on December 28, 2024.

Our findings indicate that retrobulbar hemorrhage resulting from retrobulbar blocks in ophthalmic surgery patients is exceedingly rare. The data reveal no significant difference in the incidence of retrobulbar hemorrhage between patients who are on antithrombotic medications and those who are not. Consequently, this study enhances our understanding of the importance of maintaining antithrombotic medication during ophthalmic procedures, as discontinuation may increase the risk of thromboembolic events for these patients. Please join us in congratulating Dr. Finkel and our dedicated research team on this valuable contribution to our field. Additionally, we would like to acknowledge Tamas Takata for his exceptional contributions in drafting the manuscript. For full article, please follow this link: Therapeutic Antithrombotic Agent Use and Bleeding Risk in Retrobulbar Anesthesia for Outpatient Ophthalmic Surgery

Citation: Finkel K, Takata E T, Walker A, et al. (December 28, 2024) Therapeutic Antithrombotic Agent Use and Bleeding Risk in Retrobulbar Anesthesia for Outpatient Ophthalmic Surgery. Cureus 16(12): e76515.doi:10.7759/cureus.76515